Literature DB >> 23980666

White blood cell count is positively associated with benign prostatic hyperplasia.

Kazutoshi Fujita1, Masahiro Hosomi, Masahiro Nakagawa, Go Tanigawa, Ryoichi Imamura, Motohide Uemura, Yasutomo Nakai, Hitoshi Takayama, Seiji Yamaguchi, Norio Nonomura.   

Abstract

OBJECTIVES: To determine whether low-grade systemic inflammation is associated with prostatic enlargement/benign prostatic hyperplasia.
METHODS: Prostate volume was measured by transrectal ultrasonography in 576 Japanese men. The association between prostate volume and routine clinical inflammatory markers (C-reactive protein level, white blood cell count, or the differential white cell count [neutrophils, lymphocytes, basophils, eosinophils, and monocytes]) were analyzed. Contributors to prostate volume were identified in univariate and multivariable linear regression models.
RESULTS: Prostate volume was found to have a positive association with serum prostate-specific antigen level (P < 0.001), white blood cell count (P = 0.027) and absolute neutrophil count (P = 0.010). In univariate linear regression models, a large prostate volume was associated with older age, higher prostate-specific antigen, and higher white blood cell and neutrophil counts. A multivariable model adjusted for age, prostate-specific antigen, and C-reactive protein showed that the white blood cell count and the neutrophil count were independently associated with prostate volume. An increased white blood cell count was also associated with higher total International Prostatic Symptom Scores (P < 0.001).
CONCLUSIONS: White blood cell count seems to be associated with the degree of prostate enlargement and lower urinary tract symptoms. Chronic low-grade systemic inflammation might be involved in the etiology of benign prostatic hyperplasia.
© 2013 The Japanese Urological Association.

Entities:  

Keywords:  benign prostatic hyperplasia; prostate; white blood cell count

Mesh:

Substances:

Year:  2013        PMID: 23980666     DOI: 10.1111/iju.12243

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  5 in total

Review 1.  Inflammatory mediators in the development and progression of benign prostatic hyperplasia.

Authors:  Cosimo De Nunzio; Fabrizio Presicce; Andrea Tubaro
Journal:  Nat Rev Urol       Date:  2016-09-30       Impact factor: 14.432

2.  Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer.

Authors:  Takuji Hayashi; Kazutoshi Fujita; Go Tanigawa; Atsunari Kawashima; Akira Nagahara; Takeshi Ujike; Motohide Uemura; Tetsuya Takao; Seiji Yamaguchi; Norio Nonomura
Journal:  Oncotarget       Date:  2017-05-23

3.  Detection of Prostatic Inflammation From Peripheral Lymphocyte Count and Free/Total PSA Ratio in Men With LUTS/BPH.

Authors:  Xinyang Liao; Zhuang Tang; Jianzhong Ai; Hang Xu; Shiyu Zhang; Liangren Liu; Shi Qiu; Ping Tan; Yu Fan; Lu Yang; Qiang Wei
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

4.  Tadalafil Treatment Improves Inflammation, Cognitive Function, And Mismatch Negativity Of Patients With Low Urinary Tract Symptoms And Erectile Dysfunction.

Authors:  Amparo Urios; Felipe Ordoño; Raquel García-García; Alba Mangas-Losada; Paola Leone; Juan José Gallego; Andrea Cabrera-Pastor; Javier Megías; Juan Fermin Ordoño; Vicente Felipo; Carmina Montoliu
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

5.  Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects.

Authors:  Chen Zhu; Juan Wu; Yixian Wu; Wen Guo; Jing Lu; Wenfang Zhu; Xiaona Li; Nianzhen Xu; Qun Zhang
Journal:  Front Nutr       Date:  2022-10-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.